292 related articles for article (PubMed ID: 16154999)
1. Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor.
Hemming ML; Selkoe DJ
J Biol Chem; 2005 Nov; 280(45):37644-50. PubMed ID: 16154999
[TBL] [Abstract][Full Text] [Related]
2. Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme.
Zou K; Maeda T; Watanabe A; Liu J; Liu S; Oba R; Satoh Y; Komano H; Michikawa M
J Biol Chem; 2009 Nov; 284(46):31914-20. PubMed ID: 19773553
[TBL] [Abstract][Full Text] [Related]
3. Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer disease.
Hemming ML; Selkoe DJ; Farris W
Neurobiol Dis; 2007 Apr; 26(1):273-81. PubMed ID: 17321748
[TBL] [Abstract][Full Text] [Related]
4. Conversion of Aβ43 to Aβ40 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme.
Liu S; Liu J; Miura Y; Tanabe C; Maeda T; Terayama Y; Turner AJ; Zou K; Komano H
J Neurosci Res; 2014 Sep; 92(9):1178-86. PubMed ID: 24823497
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition.
Zou K; Yamaguchi H; Akatsu H; Sakamoto T; Ko M; Mizoguchi K; Gong JS; Yu W; Yamamoto T; Kosaka K; Yanagisawa K; Michikawa M
J Neurosci; 2007 Aug; 27(32):8628-35. PubMed ID: 17687040
[TBL] [Abstract][Full Text] [Related]
6. Aβ43 is the earliest-depositing Aβ species in APP transgenic mouse brain and is converted to Aβ41 by two active domains of ACE.
Zou K; Liu J; Watanabe A; Hiraga S; Liu S; Tanabe C; Maeda T; Terayama Y; Takahashi S; Michikawa M; Komano H
Am J Pathol; 2013 Jun; 182(6):2322-31. PubMed ID: 23562443
[TBL] [Abstract][Full Text] [Related]
7. A clinical dose of angiotensin-converting enzyme (ACE) inhibitor and heterozygous ACE deletion exacerbate Alzheimer's disease pathology in mice.
Liu S; Ando F; Fujita Y; Liu J; Maeda T; Shen X; Kikuchi K; Matsumoto A; Yokomori M; Tanabe-Fujimura C; Shimokata H; Michikawa M; Komano H; Zou K
J Biol Chem; 2019 Jun; 294(25):9760-9770. PubMed ID: 31072831
[TBL] [Abstract][Full Text] [Related]
8. ACE inhibition with captopril retards the development of signs of neurodegeneration in an animal model of Alzheimer's disease.
AbdAlla S; Langer A; Fu X; Quitterer U
Int J Mol Sci; 2013 Aug; 14(8):16917-42. PubMed ID: 23959119
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline.
Bernstein KE; Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Lopes DH; Shah KH; Bernstein EA; Fuchs DT; Yu JJ; Pham M; Black KL; Shen XZ; Fuchs S; Koronyo-Hamaoui M
J Clin Invest; 2014 Mar; 124(3):1000-12. PubMed ID: 24487585
[TBL] [Abstract][Full Text] [Related]
10. Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme.
Eckman EA; Adams SK; Troendle FJ; Stodola BA; Kahn MA; Fauq AH; Xiao HD; Bernstein KE; Eckman CB
J Biol Chem; 2006 Oct; 281(41):30471-8. PubMed ID: 16912050
[TBL] [Abstract][Full Text] [Related]
11. Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease.
Koronyo-Hamaoui M; Sheyn J; Hayden EY; Li S; Fuchs DT; Regis GC; Lopes DHJ; Black KL; Bernstein KE; Teplow DB; Fuchs S; Koronyo Y; Rentsendorj A
Brain; 2020 Jan; 143(1):336-358. PubMed ID: 31794021
[TBL] [Abstract][Full Text] [Related]
12. Kinetic and structural characterization of amyloid-β peptide hydrolysis by human angiotensin-1-converting enzyme.
Larmuth KM; Masuyer G; Douglas RG; Schwager SL; Acharya KR; Sturrock ED
FEBS J; 2016 Mar; 283(6):1060-76. PubMed ID: 26748546
[TBL] [Abstract][Full Text] [Related]
13. Neurotoxic Effects of Aβ6-42 Peptides Mimicking Putative Products Formed by the Angiotensin Converting Enzyme.
Medvedev AE; Radko SP; Yurinskaya MM; Vinokurov MG; Buneeva OA; Kopylov AT; Kozin SA; Mitkevich VA; Makarov AA
J Alzheimers Dis; 2018; 66(1):263-270. PubMed ID: 30282362
[TBL] [Abstract][Full Text] [Related]
14. Catabolic attacks of membrane-bound angiotensin-converting enzyme on the N-terminal part of species-specific amyloid-beta peptides.
Sun X; Becker M; Pankow K; Krause E; Ringling M; Beyermann M; Maul B; Walther T; Siems WE
Eur J Pharmacol; 2008 Jun; 588(1):18-25. PubMed ID: 18495113
[TBL] [Abstract][Full Text] [Related]
15. Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I.
Michaud A; Williams TA; Chauvet MT; Corvol P
Mol Pharmacol; 1997 Jun; 51(6):1070-6. PubMed ID: 9187274
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme as a potential target for treatment of Alzheimer's disease: inhibition or activation?
Zou K; Michikawa M
Rev Neurosci; 2008; 19(4-5):203-12. PubMed ID: 19145983
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology.
Kehoe PG; Wong S; Al Mulhim N; Palmer LE; Miners JS
Alzheimers Res Ther; 2016 Nov; 8(1):50. PubMed ID: 27884212
[TBL] [Abstract][Full Text] [Related]
18. The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors.
Wei L; Clauser E; Alhenc-Gelas F; Corvol P
J Biol Chem; 1992 Jul; 267(19):13398-405. PubMed ID: 1320019
[TBL] [Abstract][Full Text] [Related]
19. N-domain of angiotensin-converting enzyme hydrolyzes human and rat amyloid-β(1-16) peptides as arginine specific endopeptidase potentially enhancing risk of Alzheimer's disease.
Kugaevskaya EV; Veselovsky AV; Indeykina MI; Solovyeva NI; Zharkova MS; Popov IA; Nikolaev EN; Mantsyzov AB; Makarov AA; Kozin SA
Sci Rep; 2018 Jan; 8(1):298. PubMed ID: 29321566
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of amyloid-β peptide at serine 8 attenuates its clearance via insulin-degrading and angiotensin-converting enzymes.
Kumar S; Singh S; Hinze D; Josten M; Sahl HG; Siepmann M; Walter J
J Biol Chem; 2012 Mar; 287(11):8641-51. PubMed ID: 22267728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
